Walleye Trading
ESLAW icon

Walleye Trading’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Walleye Trading’s Portfolio ESLAW Stock Details ESLAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-72,834
Closed -$3.46K – 4488
2025
Q2 		$3.46K Hold
72,834
– – ﹤0.01% 4108
2025
Q1 		$5.61K Sell
72,834
-20,136
-22% -$1.72K ﹤0.01% 3882
2024
Q4 		$8.17K Buy
92,970
+55,782
+150% +$4.75K ﹤0.01% 4046
2024
Q3 		$2.6K Hold
37,188
– – ﹤0.01% 3901
2024
Q2 		$2.57K Hold
37,188
– – ﹤0.01% 4040
2024
Q1 		$2.47K Hold
37,188
– – ﹤0.01% 4504
2023
Q4 		$1.12K Buy
+37,188
New +$2.9K ﹤0.01% 4902

Other funds holding ESLAW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Walleye Trading's ESLAW Position: Q3 2025 in Review

Walleye Trading sold out of Estrella Immunopharma Warrant (ESLAW) in Q3 2025, closing a stake of 72,834 shares — an estimated $3.46K sold.

Walleye Trading first reported a position in ESLAW in Q4 2023 and held it in 7 quarters. The position peaked at $8.17K in Q4 2024. 12 funds tracked by Wall St. Rank hold ESLAW as of Q3 2025.

  • Walleye Trading reported no remaining Estrella Immunopharma Warrant position as of Q3 2025 after selling out during the quarter.
  • Walleye Trading sold 72,834 Estrella Immunopharma Warrant shares in Q3 2025, an estimated $3.46K.
  • Walleye Trading first reported a position in Estrella Immunopharma Warrant in Q4 2023 and held it in 7 quarters.
  • Walleye Trading's Estrella Immunopharma Warrant position peaked at $8.17K in Q4 2024.
  • 12 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q3 2025.

Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.